147 related articles for article (PubMed ID: 3463778)
1. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
[TBL] [Abstract][Full Text] [Related]
4. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of aclacinomycin A in mice, rabbits and dogs by photometric assay (author's transl)].
Iguchi H; Matsushita Y; Ohmori K; Hirano S; Kiyosaki T; Hori S; Tone H; Oki T
Jpn J Antibiot; 1980 Feb; 33(2):179-91. PubMed ID: 6929360
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs.
Iguchi H; Tone H; Kiyosaki T; Ishikura T; Takeuchi T; Umezawa H
Jpn J Antibiot; 1986 Feb; 39(2):638-52. PubMed ID: 3712763
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and action mechanism of anthracyclines].
Fukushima T; Ueda T; Nakamura T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
Jaenke RS; Deprez-DeCampeneere D; Trouet A
Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic study of aclarubicin. The distribution of the preparation and its biologically active metabolites in rat tissues].
Firsov AA; Geodakian SV; Egorov LV; Terent'eva TG
Antibiot Med Biotekhnol; 1987 Oct; 32(10):773-7. PubMed ID: 3480700
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of adriamycin in the rat.
Tavoloni N; Guarino AM
Pharmacology; 1980; 21(4):244-55. PubMed ID: 7422708
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
14. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
Cummings J; Merry S; Willmott N
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
[TBL] [Abstract][Full Text] [Related]
15. Murine metabolism and disposition of iron:adriamycin complexes.
Egorin MJ; Clawson RE; Ross LA; Friedman RD; Reich SD; Pollak A; Bachur NR
Cancer Res; 1983 Jul; 43(7):3253-62. PubMed ID: 6189594
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
Majima H; Iguchi H; Tone H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
Preiss R; Sohr R; Kittelmann B; Müller E; Haase D
Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):156-64. PubMed ID: 2714916
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
Majima H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin pharmacokinetics in the rabbit.
Maniez-Devos DM; Baurain R; Trouet A; Lesne M
J Pharmacol; 1985; 16(2):159-69. PubMed ID: 4058012
[TBL] [Abstract][Full Text] [Related]
20. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.
Cummings J; Milstead R; Cunningham D; Kaye S
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
